![Christiana Stamoulis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christiana Stamoulis
Director of Finance/CFO at
MALLINCKRODT PLC
Net worth: 6 M $ as of 2026-05-30
Profile
Presently, Christiana Stamoulis is Chief Financial Officer & Executive Vice President of Incyte Corp. Ms. Stamoulis is also on the board of Hologic, Inc. In her past career she was President & Chief Financial Officer at Cogent Biosciences, Inc., Senior VP-Strategy & Business Development at Vertex Pharmaceuticals, Inc., Managing Director-Investment Banking Division at Citigroup, Inc. and Vice President at Goldman Sachs & Co. LLC. Ms. Stamoulis received an undergraduate degree from Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INCYTE CORPORATION 0.03% | 2026-04-13 | 57,534 ( 0.03% ) | 6 M $ | 2026-05-30 |
Latest news about Christiana Stamoulis
Christiana Stamoulis active positions
| Companies | Position | Start |
|---|---|---|
| MALLINCKRODT PLC | Director of Finance/CFO | 2025-08-31 |
Former positions of Christiana Stamoulis
| Companies | Position | End |
|---|---|---|
| HOLOGIC, INC. | Director/Board Member | 2026-04-06 |
| INCYTE CORPORATION | Director of Finance/CFO | 2025-09-15 |
| COGENT BIOSCIENCES, INC. | Director of Finance/CFO | 2019-01-30 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2013-11-30 |
| CITIGROUP INC. | Corporate Officer/Principal | 2008-12-31 |
Training of Christiana Stamoulis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Hologic, Inc.
 Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Christiana Stamoulis
